Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer

Global estimates of cancer prevalence for 27 sites in the adult population in 2008

Freddie Bray, Jiansong Ren, E. Masuyer et al. · International Journal of Cancer · 2012 · 1.9K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Down-Regulation of β-Catenin by Activated p53

Einat Sadot, Benjamin Geiger, Moshe Oren et al. · Molecular and Cellular Biology · 2001 · 229 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA

Federica Gemignani, Vı́ctor Moreno, Stefano Landi et al. · Oncogene · 2003 · 219 citations

Medicine, Genetics, Molecular Genetics +16

Twenty years of breast cancer in Iran: downstaging without a formal screening program

Iraj Harirchi, Shadi Kolahdoozan, Mojgan Karbakhsh et al. · Annals of Oncology · 2010 · 169 citations

Medicine, Oncology, Breast Oncology +9

Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP

Yifeng Xia, Roanna C. Padre, Tatiana Hurtado de Mendoza et al. · Proceedings of the National Academy of Sciences · 2009 · 144 citations · Full text

Life Sciences, Molecular Biology, Oncology +16